Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead

Toxins
José María GutiérrezJuan J Calvete

Abstract

Animal-derived antivenoms constitute the mainstay in the therapy of snakebite envenoming. The efficacy of antivenoms to neutralize toxicity of medically-relevant snake venoms has to be demonstrated through meticulous preclinical testing before their introduction into the clinical setting. The gold standard in the preclinical assessment and quality control of antivenoms is the neutralization of venom-induced lethality. In addition, depending on the pathophysiological profile of snake venoms, the neutralization of other toxic activities has to be evaluated, such as hemorrhagic, myotoxic, edema-forming, dermonecrotic, in vitro coagulant, and defibrinogenating effects. There is a need to develop laboratory assays to evaluate neutralization of other relevant venom activities. The concept of the 3Rs (Replacement, Reduction, and Refinement) in Toxinology is of utmost importance, and some advances have been performed in their implementation. A significant leap forward in the study of the immunological reactivity of antivenoms against venoms has been the development of "antivenomics", which brings the analytical power of mass spectrometry to the evaluation of antivenoms. International partnerships are required to assess the preclinical ...Continue Reading

References

Dec 11, 1975·The American Journal of Physiology·R W CarlsonM H Weil
Jan 1, 1991·Toxicon : Official Journal of the International Society on Toxinology·J P ChippauxJ White
Mar 1, 1989·Agents and Actions·H A Trebien, J B Calixto
Oct 1, 1989·Biochemical Pharmacology·A BdolahE Kochva
Jan 1, 1988·Toxicon : Official Journal of the International Society on Toxinology·J M GutiérrezL Cerdas
Jan 1, 1987·Toxicon : Official Journal of the International Society on Toxinology·J M GutiérrezL Cerdas
Jan 1, 1985·Toxicon : Official Journal of the International Society on Toxinology·J M GutiérrezL Cerdas
Jan 1, 1985·Toxicon : Official Journal of the International Society on Toxinology·M M Azevedo-MarquesC J Laure
Jun 1, 1984·Experimental and Molecular Pathology·J M GutiérrezG V Odell
Jan 1, 1984·Toxicon : Official Journal of the International Society on Toxinology·C L OwnbyG V Odell
Jan 1, 1980·Toxicon : Official Journal of the International Society on Toxinology·J M GutiérrezR Bolaños
Jan 1, 1981·Toxicon : Official Journal of the International Society on Toxinology·J M GutiérrezE Portilla
Jun 1, 1995·Toxicon : Official Journal of the International Society on Toxinology·R OteroL E Posada
Jan 1, 1995·Toxicon : Official Journal of the International Society on Toxinology·F ChavesJ M Gutiérrez
Mar 1, 1994·Toxicon : Official Journal of the International Society on Toxinology·A L HarveyJ B Harris
Jun 1, 1993·Toxicon : Official Journal of the International Society on Toxinology·C L OwnbyT R Colberg
Jul 15, 1997·Thrombosis Research·I S Sano-MartinsR D Theakston
Dec 24, 1997·Toxicon : Official Journal of the International Society on Toxinology·P G SellsR D Theakston
Aug 5, 1998·Toxicon : Official Journal of the International Society on Toxinology·A R de RoodtS E Hajos
Oct 29, 1998·Toxicon : Official Journal of the International Society on Toxinology·M Ismail, M A Abd-Elsalam
Oct 29, 1998·Toxicon : Official Journal of the International Society on Toxinology·J M GutiérrezF Chaves
Jan 27, 1999·Toxicon : Official Journal of the International Society on Toxinology·B LomonteJ M Gutiérrez
Jul 14, 1999·Biologicals : Journal of the International Association of Biological Standardization·M N KrifiK Dellagi
Apr 12, 2000·Toxicon : Official Journal of the International Society on Toxinology·G BogarínJ M Gutiérrez
Aug 2, 2001·Toxicon : Official Journal of the International Society on Toxinology·W S MariaC Chávez-Olórtegui
Jul 9, 2003·Clinical Pharmacokinetics·José María GutiérrezBruno Lomonte
Jan 1, 1960·Japanese Journal of Medical Science & Biology·H KONDOR MURATA
Mar 17, 2004·Toxicon : Official Journal of the International Society on Toxinology·José María Gutiérrez, Charlotte L Ownby
Jul 13, 2004·Toxicon : Official Journal of the International Society on Toxinology·Daniela G BeghiniSérgio Marangoni
Jul 23, 2004·Thrombosis and Haemostasis·Marcelo Larami Santoro, Ida Sigueko Sano-Martins
Feb 26, 2005·Clinical and Experimental Pharmacology & Physiology·Sharmaine RamasamyWayne C Hodgson
Apr 20, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·J M GutiérrezG Rojas
Jun 1, 2005·Toxicon : Official Journal of the International Society on Toxinology·Julian White
Jun 23, 2005·Toxicon : Official Journal of the International Society on Toxinology·Daniela C S DamicoJosé Camillo Novello
May 30, 2006·PLoS Medicine·José María GutiérrezDavid A Warrell
Aug 9, 2006·Toxicon : Official Journal of the International Society on Toxinology·A RialH Massaldi

❮ Previous
Next ❯

Citations

Sep 29, 2018·Toxins·Line LedsgaardAndreas Hougaard Laustsen
Feb 19, 2019·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·D PaniaguaA Alagón
Mar 12, 2019·PLoS Neglected Tropical Diseases·María Carlina Castillo-BeltránFrancisco Javier Ruiz-Gómez
Mar 7, 2018·The Journal of Venomous Animals and Toxins Including Tropical Diseases·Victor Morais
Jul 16, 2020·Ciência & saúde coletiva·Rafael Rodrigues Matos, Eliane Ignotti
Aug 3, 2017·The Medical Journal of Australia·David A Warrell
Nov 7, 2019·Frontiers in Immunology·Karen Larissa Pereira de CastroClara Guerra-Duarte
Nov 28, 2019·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Hui Wen FanUNKNOWN en representación de la Red de Laboratorios Públicos Productores de Antivenenos de América Latina (RELAPA)
May 8, 2020·Science Translational Medicine·Cho Yeow KohR Manjunatha Kini
Aug 30, 2018·Journal of Tropical Medicine·Tommaso C BulfoneMatthew R Lewin
Dec 14, 2018·Scientific Reports·Abhijeet DhimanTarun Kumar Sharma
Feb 9, 2020·International Journal of Biological Macromolecules·Jessica B SouzaRafael Nascimento
Sep 9, 2019·Toxicon : Official Journal of the International Society on Toxinology·Letícia Lopes-de-SouzaCarlos Chávez-Olórtegui
Nov 17, 2020·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Raya AtamnaSigal Klainbart
Mar 7, 2018·Toxicon : Official Journal of the International Society on Toxinology·José María Gutiérrez
Nov 15, 2019·Toxicon : Official Journal of the International Society on Toxinology·Dabor ResiereJosé María Gutiérrez
Jun 13, 2021·International Journal of Biological Macromolecules·Carla F C FernandesRodrigo G Stabeli
Mar 28, 2019·Toxicon : Official Journal of the International Society on Toxinology·Carlos Leónidas LeivaPablo Chacana
Aug 24, 2021·Toxicon : Official Journal of the International Society on Toxinology·Joeliton Dos Santos CavalcanteCayo Almeida
Aug 26, 2021·Toxicon: X·Muhammad HamzaAbdulrazaq G Habib

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
size-exclusion chromatography
ELISAs

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.